In March 2016, Sharapova revealed she had failed a drug test at the 2016 Australian Open, admitting to testing positive for meldonium, a substance banned by the World Anti-Doping Agency (WADA) at the start of 2016. On June 8, 2016, she was suspended from playing tennis for two years by the International Tennis Federation (ITF).